Aesthetic Trends 2020: An overview

2 years ago 0

With an increased demand for beauty innovations coupled with growing wellness concerns, the medical aesthetic market is expected to embrace newer trends and techniques in

Revision treatments on the rise, says RealSelf report

2 years ago 0

RealSelf has revealed the fastest-growing cosmetic treatments of 2019 and industry predictions for 2020 in its new 2019 Aesthetics Trend Report. The 2019 Aesthetics Trend

Gender neutrality might be the next big thing

2 years ago 0

Dr Alexander Rivkin from the US talks about the changing perception of gender and the concept of gender fluidity. A Los Angeles-based cosmetic surgeon who

Facial fat transfer demand to soar, says report

2 years ago 0

Fat grafting for facial lifts to witness 10%+ increase by 2026. The global facial fat transfer market size is anticipated to reach USD 4.2 billion

How to make the most of Instagram for your business

2 years ago 0

Marketing your clinic on Instagram can prove to be a game-changer for your business. Our social media expert Ami Savla Hemani discusses key aspects of

Dr Richa’s Unique Clinic awarded

2 years ago 0

Dr Richa’s Unique Clinic, Nagpur, wins coveted award. Dr. Richa’s Unique Clinic in Nagpur won the Best Cosmetologist and Trichologist Clinic in Maharashtra at the

Skin problems on the rise in the capital

2 years ago 0

Rising pollution in Delhi-NCR takes its toll on the skin, too. As per a report in, toxic high pollution levels in Delhi-NCR is not

Mary Kay Inc. caps off landmark scientific credentialing year

2 years ago 0

73rd Society of cosmetic chemist meeting sponsored by Mary Kay Inc. to explore the application of skin with experts In 2019, Mary Kay Inc. continued

Galderma receives an optimistic upshot by European union for AKLIEF®

2 years ago 0

Galderma announced that AKLIEF® has completed the European decentralised procedure which will result in approval by all involved European member states Galderma announced that AKLIEF®

Janssen completes acquisition of investigational Bermekimab

2 years ago 0

The Janssen Pharmaceutical Companies announced the acquisition of all rights to Bermekimab, along with certain employees, from XBiotech Inc., for $750 million. The Janssen Pharmaceutical

1 2

Please fill our short form.

    Company Name (required)

    Your Name (required)

    Designation (required)

    Number (required)

    Your Email (required)